Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Croce

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Scientific Reports|March 15, 2019
The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitorsFrancesca Coperchini, Laura Croce, Marco Denegri, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 22, 2025
Redefining thyroid nodule evaluation: demographics, misleading symptoms, and diagnostic challenges. Insights from a multicenter studyLaura Croce, Rosaria Maddalena Ruggeri, Marsida Teliti, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2024
Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent StudiesMario Rotondi, Mayumi Endo, Marsida Teliti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 19, 2015
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancerFrancesca Coperchini, Patrizia Pignatti, Andrea Carbone, et al.
European Journal of Endocrinology|July 28, 2020
Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up studyMario Rotondi, Gloria Groppelli, Laura Croce, et al.
Journal of Immunology Research|November 30, 2019
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous NephropathyGiuseppe Stefano Netti, Barbara Infante, Federica Spadaccino, et al.
European Thyroid Journal|January 22, 2025
Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: A multicenter studyLaura Croce, Rosaria Maddalena Ruggeri, Camilla Virili, et al.
Frontiers in Endocrinology|June 8, 2026
Modulation of chemokine secretion and oxidative stress <i>in vitro</i> in thyroid cells after exposure to thiocyanate, nitrate, or perchlorateAlessia Greco, Francesca Coperchini, Elena Franchi, et al.
Frontiers in Endocrinology|October 3, 2022
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADSLorenzo Scappaticcio, Pierpaolo Trimboli, Sergio Iorio, et al.
Clinical Kidney Journal|July 24, 2020
Nocturnal haemodialysis is associated with a reduced occurrence of low triiodothyronine serum levels in haemodialysed patientsGiuseppe Stefano Netti, Mario Rotondi, Adelaide Di Lorenzo, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Scientific Reports|March 15, 2019
The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitorsFrancesca Coperchini, Laura Croce, Marco Denegri, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 22, 2025
Redefining thyroid nodule evaluation: demographics, misleading symptoms, and diagnostic challenges. Insights from a multicenter studyLaura Croce, Rosaria Maddalena Ruggeri, Marsida Teliti, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2024
Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent StudiesMario Rotondi, Mayumi Endo, Marsida Teliti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 19, 2015
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancerFrancesca Coperchini, Patrizia Pignatti, Andrea Carbone, et al.
European Journal of Endocrinology|July 28, 2020
Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up studyMario Rotondi, Gloria Groppelli, Laura Croce, et al.
Journal of Immunology Research|November 30, 2019
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous NephropathyGiuseppe Stefano Netti, Barbara Infante, Federica Spadaccino, et al.
European Thyroid Journal|January 22, 2025
Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: A multicenter studyLaura Croce, Rosaria Maddalena Ruggeri, Camilla Virili, et al.
Frontiers in Endocrinology|June 8, 2026
Modulation of chemokine secretion and oxidative stress <i>in vitro</i> in thyroid cells after exposure to thiocyanate, nitrate, or perchlorateAlessia Greco, Francesca Coperchini, Elena Franchi, et al.
Frontiers in Endocrinology|October 3, 2022
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADSLorenzo Scappaticcio, Pierpaolo Trimboli, Sergio Iorio, et al.
Clinical Kidney Journal|July 24, 2020
Nocturnal haemodialysis is associated with a reduced occurrence of low triiodothyronine serum levels in haemodialysed patientsGiuseppe Stefano Netti, Mario Rotondi, Adelaide Di Lorenzo, et al.
Pageof 6